Target intelligence / Profile preview

Serine/threonine-protein kinase WEE1 (WEE1)

Target
WEE1
Molecular classification
Enzyme, Protein Kinase, Serine/Threonine Kinase, Tyrosine Kinase
01

Overview

Serine/threonine-protein kinase WEE1 is a nuclear kinase that inhibits CDK1/cyclin B, preventing premature entry into mitosis. It plays a crucial role in the G2/M checkpoint, DNA damage response, and cell size control. WEE1 is a therapeutic target in cancer, with inhibitors designed to induce mitotic catastrophe in tumor cells.

Other names
WEE1 kinaseWEE1-like protein kinase
02

Mechanism of action

Inhibition of WEE1 prevents inhibitory phosphorylation of CDK1, leading to premature mitotic entry and mitotic catastrophe, particularly in cancer cells with defective G1 checkpoints. Selectivity against tumor cells due to reliance on G2/M checkpoint.

03

Biological functions

Cell cycle regulationG2/M checkpoint controlDNA damage responseCell size controlHistone modification
04

Disease associations

Cancer
05

Safety considerations

Potential for off-target effectsToxicity when combined with other chemotherapeutic agentsMitotic catastrophe can lead to complex cellular responses

Beyond the preview

Go deeper on Serine/threonine-protein kinase WEE1 (WEE1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine/threonine-protein kinase WEE1 (WEE1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call